SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)
$10.91 -0.0276 (-0.2523%)
Analysed SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) News Sources
RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1%
08-01-2026
yahoo.com
Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million
22-09-2026
yahoo.com
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
01-10-2026
yahoo.com
What is the current price of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?
The current price of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is $10.91.
SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) since the previous trading day is $-0.0276.
SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) since the previous trading day is -0.2523%.
What is the most recent average sentiment score for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?
The most recent average sentiment score for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is 65 out of 100.
What is the most recent average sentiment for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?
The most recent sentiment for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is .
SEC-8K** Filing Available For SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.